Presentation ESC 2014 Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study Presenter: Petr Widimsky September 02, 2014
Presentation ESC 2014 10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial Presenter: Robert A. Henderson September 02, 2014
News Conference News ESC 2014 MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk Yael L. Maxwell September 02, 2014
News Conference News ESC 2014 IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI Todd Neale September 02, 2014
News Conference News ESC 2014 GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular Caitlin E. Cox September 02, 2014
News Conference News ESC 2014 FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years Caitlin E. Cox September 02, 2014
News Conference News ESC 2014 Another Strike Against Thrombectomy in 1-Year TASTE Results Todd Neale September 02, 2014
Presentation ESC 2014 Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization Presenter: Thomas Pilgrim September 01, 2014
News Conference News ESC 2014 NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin Caitlin E. Cox September 01, 2014
News Conference News ESC 2014 FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI Todd Neale September 01, 2014
News Conference News ESC 2014 CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients Caitlin E. Cox September 01, 2014
News Conference News ESC 2014 BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial Yael L. Maxwell September 01, 2014
News Conference News ESC 2014 ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration Yael L. Maxwell September 01, 2014
News Conference News ESC 2014 SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS Yael L. Maxwell August 31, 2014
News Conference News ESC 2014 Observational Studies Ask How Much Medication Adherence Matters After MI Caitlin E. Cox August 31, 2014
News Conference News ESC 2014 APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI Yael L. Maxwell August 31, 2014
Presentation ESC 2014 SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents Presenter: Christoph Varenhorst August 30, 2014
News Conference News ESC 2014 SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES Todd Neale August 30, 2014
News Conference News ESC 2014 Post-Acute MI Survival Improving for Elderly Patients in France Todd Neale August 30, 2014
News Conference News ESC 2013 FFR-Guided CABG Reduces Number of Grafts in Patients with Intermediate Stenosis September 04, 2013